Frontlight ResearchEarly access
Childhood cancers trials in United States
933 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleBiologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial
- Where
- Phoenix, Rochester
- Age
- 2 years and over
- People
- 170
- Run by
- Mayo Clinic
See details and how to joinNCT07188532 - Phase 2Taking peopleEflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
- Where
- Hershey, Portland, Tampa
- Age
- 0 years to 50 years
- People
- 406
- Run by
- Milton S. Hershey Medical Center
See details and how to joinNCT07321912 - No phaseTaking peopleMolecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
- Where
- New York
- People
- 2,070
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT00588068 - No phaseTaking peopleProton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy
- Where
- Atlanta, Baltimore, Boston, Chapel Hill, Columbus, Houston, Irving, Jacksonville, Knoxville, Liberty Township, New York, Oklahoma City, Palo Alto, Philadelphia, Rochester, Salt Lake City, San Diego, San Francisco, Seattle, Somerset, St Louis, Syracuse, Warrenville
- Age
- Up to 21 years
- People
- 5,000 worldwide
- Run by
- Massachusetts General Hospital
See details and how to joinNCT01696721 - No phaseTaking peopleNeurocutaneous Melanocytosis Registry
- Where
- Boston, New York
- People
- 100
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04548817 - No phaseTaking peopleData Collection Study of Pediatric and Adolescent Gynecology Conditions
- Where
- Bethesda
- Age
- 1 day to 100 years
- People
- 11,000
- Run by
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
See details and how to joinNCT04717349 - No phaseTaking peoplePediRISE Feasibility
- Where
- Boston, New York, San Francisco
- Age
- Up to 17 years
- People
- 40
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT06283251 - No phaseTaking peopleNIDCD Otolaryngology Clinical Protocol Biospecimen Bank
- Where
- Bethesda
- Age
- 3 years to 99 years
- People
- 1,000
- Run by
- National Institute on Deafness and Other Communication Disorders (NIDCD)
See details and how to joinNCT06303180 - No phaseTaking peopleKinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation
- Where
- Duarte
- Age
- 7 years and over
- People
- 75
- Run by
- City of Hope Medical Center
See details and how to joinNCT07235501 - Phase 1Taking peopleA Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
- Where
- Atlanta, Dallas, Nashville, Palo Alto, Valhalla
- Age
- 6 months to 17 years
- People
- 18 worldwide
- Run by
- AbbVie
See details and how to joinNCT07306832 - Phase 2Not yet taking people in United StatesEfficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade Glioma
- Where
- Birmingham
- Age
- 12 years to 89 years
- People
- 55
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT07521657 - Phase 1Taking peopleActivated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- Where
- Houston
- Age
- Up to 75 years
- People
- 64
- Run by
- Baylor College of Medicine
See details and how to joinNCT01853631 - Phase 1Taking peopleCD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
- Where
- Houston
- Age
- 12 years to 75 years
- People
- 60
- Run by
- Baylor College of Medicine
See details and how to joinNCT02917083 - Phase 1/2Taking peopleThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Where
- Austin, Bedford, Boston, Charleston, Cleveland, Dallas, Denver, Detroit, Durham, Fairfax, Houston, Irvine, La Jolla, Los Angeles, Madison, Miami, Nashville, Newark, New Haven, New York, Oklahoma City, Orlando, Philadelphia, Pittsburgh, Port Charlotte, Portland, San Antonio, Seattle, York
- Age
- 12 years and over
- People
- 300 worldwide
- Run by
- PMV Pharmaceuticals, Inc
See details and how to joinNCT04585750 - Phase 1Taking peopleConstitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
- Where
- Houston
- Age
- 12 years to 75 years
- People
- 90
- Run by
- Baylor College of Medicine
See details and how to joinNCT06176690 - Phase 1Taking peopleStudy of Cabozantinib With Selumetinib for Plexiform Neurofibromas
- Where
- Birmingham, Boston, Cincinnati, Dallas, Indianapolis, Los Angeles, Philadelphia, Washington D.C.
- Age
- 16 years and over
- People
- 30
- Run by
- Girish Dhall, MD
See details and how to joinNCT06502171 - No phaseTaking peopleMCT for the Harvard/UCSF ROBIN Center
- Where
- Boston, San Francisco
- People
- 47
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT06000787 - No phaseTaking peopleSomatic Mosaicism in Twins Discordant for Childhood Cancer
- Where
- Minneapolis
- Age
- Up to 18 years
- People
- 50
- Run by
- Children's Oncology Group
See details and how to joinNCT06054295 - No phaseTaking peopleUncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing
- Where
- Bethesda
- Age
- 2 years to 100 years
- People
- 100
- Run by
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
See details and how to joinNCT06749366 - Phase 1/2Taking peopleA Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
- Where
- West Valley City
- People
- 64 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07602777 - Phase 1/2Not yet taking people in United StatesPhase 1/2 Study Of PARP Inhibition With Olaparib To Enhance The Efficacy Of High-Dose Chemotherapy In Refractory And Relapsed Germ Cell Tumors
- Where
- Houston
- Age
- 12 years to 60 years
- People
- 36
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07850973 - Phase 1Taking peopleAtezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
- Where
- Atlanta
- Age
- Up to 50 years
- People
- 12
- Run by
- Emory University
See details and how to joinNCT06492954 - No phaseTaking peopleRegistry Study for Radiation Therapy Outcomes
- Where
- Atlanta, Baltimore, Charlotte, Cincinnati, Delray Beach, Fairfax, Flint, Fort Myers, Franklin, Hampton, Irving, Jacksonville, Kansas City, Knoxville, Little Rock, Miami, New York, Oklahoma City, Orlando, Overland Park, Peoria, San Diego, Scottsdale, Seattle, Shreveport, Somerset, St Louis, Warrenville
- People
- 50,000
- Run by
- Proton Collaborative Group
See details and how to joinNCT01255748 - Phase 1Taking peopleA Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Where
- Atlanta, Columbus, Duarte, Hackensack, Houston, Kansas City, Milwaukee, New York, Sacramento, Seattle, Stanford, Tampa
- Age
- 12 years to 78 years
- People
- 300
- Run by
- Orca Biosystems, Inc.
See details and how to joinNCT03802695 - Phase 1/2Taking peoplePanitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures
- Where
- Stanford
- Age
- 6 months to 25 years
- People
- 12
- Run by
- Stanford University
See details and how to joinNCT04085887